The perception of GLP-1s — and the people who use them — is getting better, but work still must be done to avoid stigma.

New insurance formulary trims costs of Alzheimer's and cancer therapies and marks a small win for global novel drug makers ...

AbbVie, Bristol Myers Squibb, Gilead, Merck and other drugmakers are expected on Friday afternoon ​to announce agreements ...

Eli Lilly stock hits a 90+ Quality score. BofA calls LLY underpriced, citing major growth ahead for its oral obesity drug.

Lilly has now submitted a new drug application (NDA) for orforglipron to the FDA for use in adults with obesity.

From an Eli Lilly campus where pharmaceuticals are made to a new medical school and innovation district, the Charlotte region ...

The partnership aims to make Pfizer’s medicines widely available across India using Cipla’s reach, the companies said.

Jessica Lin and Zhenqi (Pete) Shi from Genentech describe a novel machine learning approach to predicting retention times for ...

The pills are expected to cost much less then shots of blockbuster drugs like Zepbound and Wegovy. Mr. Funk was the managing ...

The Marketing + Media Alliance (MMA) proudly announces the winners of the SMARTIES™ X Global 2025 Awards, recognizing the world’s most effective and innovative marketing campaigns. This year’s program ...

The U.S. Bio-Security Act has been passed. According to KoreaBio’s Bioeconomy Research Center on the 19th, U.S. President ...

The pharmaceutical leader has established itself as the leader in the fast-growing weight loss market. And although many ...